Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia

International Journal of Hematology

Volumn 83, Issue 4, 2006, Pages 351-355

  Hishizawa, Masakatsu ^a   Imada, Kazunori ^a   Sakai, Tomomi ^a   Nishikori, Momoko ^a   Arima, Nobuyoshi ^b   Tsudo, Mitsuru ^b   Ishikawa, Takayuki ^a   Uchiyama, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Adult T cell leukemia; Allogeneic hematopoietic stem cell transplantation; AMFR; Graft versus leukemia effect; SEREX

Indexed keywords

AUTOCRINE MOTILITY FACTOR RECEPTOR; COMPLEMENTARY DNA; GLYCOSYLATED TRANSMEMBRANE PROTEIN; MEMBRANE PROTEIN; TUMOR REJECTION ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; ARTICLE; CANCER REGRESSION; CASE REPORT; CONTROLLED STUDY; DNA LIBRARY; FEMALE; GENE EXPRESSION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SEROLOGICAL IDENTIFICATION OF ANTIGENS BY RECOMBINANT CDNA EXPRESSION CLONING; T CELL LEUKEMIA; TESTIS; TUMOR IMMUNITY; TUMOR REJECTION;

ANTIBODY FORMATION; ANTIGENS, NEOPLASM; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION; GENE LIBRARY; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; ORGAN SPECIFICITY; RECEPTORS, CYTOKINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33744454931     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05173     Document Type: Article

References (39)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481-92.
2. Shimoyama M, Ota K, Kikuchi M, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol. 1988;6:1088-1097.
3. Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:15-20.
4. Kami M, Hamaki T, Miyakoshi S, et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol. 2003;120:304-309.
5. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/ lymphoma. Blood. 2005;105:4143-4145.
6. Fukushima T, Miyazaki Y, Honda S, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia. 2005;19: 829-834.
7. Hishizawa M, Imada K, Ishikawa T, Uchiyama T. Kinetics of proviral DNA load, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation. Leukemia. 2004;18:167-169.
8. Sahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA. 1995;92:11810-11813.
9. Watanabe H, Carmi P, Hogan V, et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem. 1991;266:13442-13448.
10. Koga H, Imada K, Ueda M, Hishizawa M, Uchiyama T. Identification of differentially expressed molecules in adult T-cell leukemia cells proliferating in vivo. Cancer Sci. 2004;95:411-417.
11. Kiniwa Y, Fujita T, Akada M, et al. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma. Cancer Res. 2001;61:7900-7907.
12. Hishizawa M, Imada K, Sakai T, Ueda M, Hori T, Uchiyama T. Serological identification of adult T-cell leukaemia-associated antigens. Br J Haematol. 2005;130:382-390.
13. Bellucci R, Wu CJ, Chiaretti S, et al. Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens. Blood. 2004;103: 656-663.
14. Hishizawa M, Imada K, Sakai T,. Ueda M, Uchiyama T. Identification of APOBEC3B as a potential target for the graft-versus-lymphoma effect by SEREX in a patient with mantle cell lymphoma. Br J Haematol. 2005;130:418-421.
15. Losses IS, Jones CD, Warnke R, et al. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood. 2001;98:945-951.
16. Jutras I, Reudelhuber TL. Prorenin processing by cathepsin B in vitro and in transfected cells. FEBS Lett. 1999;443:48-52.
17. Moin K, Day NA, Sameni M, Hasnain S, Hirama T, Sloane BF. Human tumour cathepsin B: comparison with normal liver cathepsin B. Biochem J. 1992;285:427-434.
18. Mach L, Schwihla H, Stuwe K, Rowan AD, Mort JS, Glossl J. Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself. Biochem J. 1993;293:437-442.
19. Hirai K, Yokoyama M, Asano G, Tanaka S. Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol. 1999; 30:680-686.
20. Werle B, Kraft C, Lah TT, et al. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma. Cancer. 2000;89:2282-2291.
21. Eijan AM, Sandes EO, Riveros MD, et al. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion. Cancer. 2003;98:262-268.
22. Liotta LA, Mandler R, Murano G, et al. Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A. 1986;83:3302-3306.
23. Harashima N, Kurihara K, Utsunomiya A, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64:391-399.
24. Franchini G. Wong-Staal F, Gallo RC. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc Natl Acad Sci U S A. 1984;81:6207-6211.
25. Kinoshita T, Shimoyama M, Tobinai K, et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA. 1989;86:3620-5624.
26. + cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol. 1991;3:761-767.
27. Tanaka Y, Oda S, Nagata K, et al. Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers. J Clin Immunol. 1989;9:477-484.
28. Hishizawa M, Imada K, Kitawaki T, Ueda M, Kadowaki N, Uchiyama T. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br J Haematol. 2004; 125:568-575.
29. Nakamori S, Watanabe H, Kameyama M, et al. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer. 1994;74:1855-1862.
30. Otto T, Birchmeier W, Schmidt U, et al. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res. 1994;54: 3120-3123.
31. Maruyama K, Watanabe H, Shiozaki H, et al. Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma. Int J Cancer. 1995;64:316-321.
32. Taniguchi K, Yonemura Y, Nojima N, et al. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. Cancer. 1998;82:2112-2122.
33. Ohta Y, Minato H, Tanaka Y, Go T, Oda M, Watanabe Y. Autocrine motility factor receptor expression associates with tumor progression thymoma. Int J Oncol. 2000;17:259-264.
34. Takanami I, Takeuchi K, Watanabe H, Yanagawa T, Takagishi K, Raz A. Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer. Int J Cancer. 2001;95:384-387.
35. Bellucci R, Alyea EP, Chiaretti S, et al. Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor. Blood. 2005; 105:3945-3950.
36. Zhang M, Zhang Z, Garmestani K, et al. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult T-cell leukemia. Cancer Res. 2004;64:5825-5829.
37. Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody. Campath-1H. Cancer Res. 2003;63:6453-6457.
38. Zhang Z, Zhang M, Ravetch JV, Goldman C, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507. Blood. 2003;102:284-288.
39. Ishida T, Iida S, Akatsuka Y, et al. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res. 2004;10:7529-7539.